262 related articles for article (PubMed ID: 31374239)
1. Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes.
Ghafelehbashi R; Akbarzadeh I; Tavakkoli Yaraki M; Lajevardi A; Fatemizadeh M; Heidarpoor Saremi L
Int J Pharm; 2019 Oct; 569():118580. PubMed ID: 31374239
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
[TBL] [Abstract][Full Text] [Related]
3. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus.
Akbarzadeh I; Keramati M; Azadi A; Afzali E; Shahbazi R; Chiani M; Norouzian D; Bakhshandeh H
Chem Phys Lipids; 2021 Jan; 234():105019. PubMed ID: 33232724
[TBL] [Abstract][Full Text] [Related]
4. Preparation and optimization of ciprofloxacin encapsulated niosomes: A new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus.
Mirzaie A; Peirovi N; Akbarzadeh I; Moghtaderi M; Heidari F; Yeganeh FE; Noorbazargan H; Mirzazadeh S; Bakhtiari R
Bioorg Chem; 2020 Oct; 103():104231. PubMed ID: 32882442
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a novel antiacne niosomal gel of rosmarinic acid.
Budhiraja A; Dhingra G
Drug Deliv; 2015; 22(6):723-30. PubMed ID: 24786487
[TBL] [Abstract][Full Text] [Related]
8. Fabrication and optimization of amoxicillin-loaded niosomes: an appropriate strategy to increase antimicrobial and anti-biofilm effects against multidrug-resistant
Shadvar P; Mirzaie A; Yazdani S
Drug Dev Ind Pharm; 2021 Oct; 47(10):1568-1577. PubMed ID: 35007176
[TBL] [Abstract][Full Text] [Related]
9. Niosome-encapsulated tobramycin reduced antibiotic resistance and enhanced antibacterial activity against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
Hedayati Ch M; Abolhassani Targhi A; Shamsi F; Heidari F; Salehi Moghadam Z; Mirzaie A; Behdad R; Moghtaderi M; Akbarzadeh I
J Biomed Mater Res A; 2021 Jun; 109(6):966-980. PubMed ID: 32865883
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of a novel thermosensitive and bioadhesive cephalexin nanohydrogel: a promising platform for topical antibacterial delivery.
Salatin S; Lotfipour F; Jelvehgari M
Expert Opin Drug Deliv; 2020 Jun; 17(6):881-893. PubMed ID: 32441175
[TBL] [Abstract][Full Text] [Related]
11. Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.
Sohrabi S; Haeri A; Mahboubi A; Mortazavi A; Dadashzadeh S
Int J Biol Macromol; 2016 Apr; 85():625-33. PubMed ID: 26794314
[TBL] [Abstract][Full Text] [Related]
12. Chitosan -based nanoniosome for potential wound healing applications: Synergy of controlled drug release and antibacterial activity.
Pourseif T; Ghafelehbashi R; Abdihaji M; Radan N; Kaffash E; Heydari M; Naseroleslami M; Mousavi-Niri N; Akbarzadeh I; Ren Q
Int J Biol Macromol; 2023 Mar; 230():123185. PubMed ID: 36623618
[TBL] [Abstract][Full Text] [Related]
13. Bioresponsive gingerol-loaded alginate-coated niosomal nanoparticles for targeting intracellular bacteria and cancer cells.
Pashizeh F; Mansouri A; Bazzazan S; Abdihaji M; Khaleghian M; Bazzazan S; Rezei N; Eskandari A; Mashayekhi F; Heydari M; Tavakkoli Yaraki M
Int J Biol Macromol; 2024 Feb; 258(Pt 2):128957. PubMed ID: 38154726
[TBL] [Abstract][Full Text] [Related]
14. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
15. Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.
Ferreira IS; Bettencourt A; Bétrisey B; Gonçalves LM; Trampuz A; Almeida AJ
Int J Pharm; 2015 May; 485(1-2):171-82. PubMed ID: 25772414
[TBL] [Abstract][Full Text] [Related]
16. Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay.
Hajizadeh MR; Parvaz N; Barani M; Khoshdel A; Fahmidehkar MA; Mahmoodi M; Torkzadeh-Mahani M
Daru; 2019 Jun; 27(1):329-339. PubMed ID: 31134490
[TBL] [Abstract][Full Text] [Related]
17. Cephalexin microspheres for dairy mastitis: effect of preparation method and surfactant type on physicochemical properties of the microspheres.
Chaisri W; Hennink WE; Ampasavate C; Okonogi S
AAPS PharmSciTech; 2010 Jun; 11(2):945-51. PubMed ID: 20509056
[TBL] [Abstract][Full Text] [Related]
18. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization.
Moghassemi S; Hadjizadeh A; Hakamivala A; Omidfar K
AAPS PharmSciTech; 2017 Jan; 18(1):34-41. PubMed ID: 27502406
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37.
Sadeghi S; Bakhshandeh H; Ahangari Cohan R; Peirovi A; Ehsani P; Norouzian D
Int J Nanomedicine; 2019; 14():9777-9792. PubMed ID: 31849468
[TBL] [Abstract][Full Text] [Related]
20. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells.
Akbarzadeh I; Saremi Poor A; Yaghmaei S; Norouzian D; Noorbazargan H; Saffar S; Ahangari Cohan R; Bakhshandeh H
Drug Dev Ind Pharm; 2020 Sep; 46(9):1535-1549. PubMed ID: 32808813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
